Market Outlook
The global Pharmaceutical Starch market size was valued at USD 1160 million in 2022 and is forecast to a readjusted size of USD 1826.4 million by 2029 with a CAGR of 6.7% during review period.
Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.
There are many players in the market, Tereos, Cargill, Roquette, Visco Starch, Colorcon and others are playing important roles in Pharmaceutical Starch industry. Top 5 players occupied about 15.29% market revenue share in 2019, The market is not concentrated for now and is still to be dispersed. Pharmaceutical starch is widely used as a binding and disintegrating agent for tablets, pills and granules, also used as filler for capsules. By application, Tablets is the largest consumer group, with consumption market share of 57.1% in 2019. Then followed by the Capsule which account for 22.3%.
There are many different types of Pharmaceutical Starch. Based on the major consumption types, the market can be segmented into: Corn Starch, Potato Starch and Others. Corn Starch is the most commonly used types and took 90.7% market share in 2019, while Potato Starch took 6.8% market share and other types took 2.5% in 2019. As for consumption market, revenue of Pharmaceutical Starch in United States took about 30.1% market share in 2019, which is the biggest consumption country in current market pattern. China ranks the second largest consumption country, with market share of 9.7% in 2019.
This report is a detailed and comprehensive analysis for global Pharmaceutical Starch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical Starch market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Pharmaceutical Starch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Pharmaceutical Starch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Pharmaceutical Starch market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Starch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Starch market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Tereos
Cargill
Roquette
Visco Starch
Colorcon
Agrana
Paramesu Biotech
Shandong Liaocheng E Hua Pharmaceutical
SPAC Starch Products (India) Limited
Sanstar Biopolymers Ltd
Ingredion
Shandong Liujia
Universal Starch-Chem Allied Ltd
Hunan Er-Kang Pharmaceutical
Jiangxi Yipusheng Pharmaceutical
Shanxi Mr G Pharmaceutical
Shivangan Food & Pharma
Splenor Starch LLP
Weifang Shengtai Medicine
Taishan Jinantang
Anhui Sunhere Pharmaceutical Excipients
Segmentation By Type
Corn Starch
Potato Starch
Others
Segmentation By Application
Tablets
Capsule
Granular Formulation
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the pharmaceutical starch market in 2025?
The pharmaceutical starch market in 2025 is expected to benefit from its essential role as an excipient in drug formulation, offering stability and improved bioavailability. Additionally, the increasing demand for natural and plant-based ingredients in healthcare products will enhance its appeal, as starch is a renewable, eco-friendly resource.
How does the pharmaceutical starch market present opportunities in 2025?
With the growing focus on personalized medicine and the rising number of chronic diseases, pharmaceutical starches can help in creating more tailored drug delivery systems. Innovations in starch-based formulations, such as the development of modified starches for controlled release drugs, will likely offer new opportunities for market expansion.
What weaknesses exist in the pharmaceutical starch market in 2025?
The reliance on raw agricultural materials like corn and potatoes can lead to supply chain disruptions due to seasonal variations or climate-related issues. Additionally, there are concerns about starch-based excipients’ potential to cause allergies in some patients, which could limit their use in certain formulations.
What threats could impact the pharmaceutical starch market in 2025?
Regulatory challenges around the use of natural excipients could increase, particularly as stricter policies on food and drug safety are enforced. Moreover, the rise of synthetic alternatives or other excipients with better functionalities may pose a threat, potentially reducing the demand for traditional pharmaceutical starches.
Market PESTEL Analysis
What political factors could impact the pharmaceutical starch market in 2025?
Government regulations and policies related to agriculture, particularly around GMO crops, could affect the availability of starches used in pharmaceuticals. Trade agreements or tariffs on raw materials from major suppliers may also impact costs and market dynamics, especially with global sourcing of ingredients.
How could the economic environment influence the pharmaceutical starch market in 2025?
Economic conditions, particularly inflation rates and raw material costs, could influence the pricing of starches. Additionally, increased healthcare spending in emerging markets could drive demand for pharmaceutical products containing starch-based excipients, creating new growth opportunities for manufacturers.
What social trends might affect the pharmaceutical starch market in 2025?
The growing trend toward natural and plant-based products in healthcare will likely benefit the pharmaceutical starch market, as consumers and manufacturers increasingly prefer excipients derived from renewable, eco-friendly sources. However, rising awareness of food allergies and sensitivities may limit starch usage in some drug formulations.
What technological advancements could influence the pharmaceutical starch market in 2025?
Technological innovations in drug delivery systems, such as controlled release formulations and nanotechnology, could enhance the functionality of starch as an excipient. Furthermore, advances in biotechnology could lead to the development of more efficient and sustainable starch production methods.
What environmental factors could impact the pharmaceutical starch market in 2025?
Environmental concerns regarding the sustainability of agriculture used for starch production may lead to pressure on producers to adopt more eco-friendly practices. Additionally, climate change may affect crop yields, potentially leading to volatility in the supply of starch-derived materials.
What legal factors should be considered for the pharmaceutical starch market in 2025?
The pharmaceutical starch market must comply with evolving regulations around excipient safety and quality standards. Intellectual property rights surrounding the use of modified starches or new starch formulations could also play a role in shaping competitive dynamics within the industry.
Market SIPOC Analysis
Who are the suppliers in the pharmaceutical starch market in 2025?
Suppliers in the pharmaceutical starch market include agricultural producers (corn, potatoes, and other starch-rich crops), specialized starch manufacturers, and biotechnology companies focused on producing modified or functional starches. These suppliers provide raw materials and innovative starch solutions for pharmaceutical applications.
What are the inputs required for the pharmaceutical starch market in 2025?
Inputs required in the pharmaceutical starch market include raw agricultural materials, processing equipment, and technology for starch modification. Additionally, compliance with regulatory standards and quality control measures are crucial inputs for producing safe and effective starch-based excipients.
What are the processes involved in the pharmaceutical starch market in 2025?
The processes include the cultivation and harvesting of starch-rich crops, extraction and refining of starch, modification through physical or chemical methods, quality testing, and packaging for pharmaceutical use. These processes ensure that starches meet the stringent requirements for use in drug formulations.
Who are the customers in the pharmaceutical starch market in 2025?
Customers include pharmaceutical companies, contract manufacturers, and drug formulators who use starch as an excipient in oral tablets, capsules, and other drug delivery systems. Additionally, healthcare product manufacturers using starch in nutraceuticals or supplements are key customers.
What are the outputs of the pharmaceutical starch market in 2025?
The outputs are pharmaceutical-grade starches used in the production of solid oral dosage forms like tablets, capsules, and powders. These outputs are designed to improve drug stability, bioavailability, and patient compliance, meeting the demand for high-quality excipients in pharmaceutical products.
Market Porter's Five Forces
How intense is the threat of new entrants in the pharmaceutical starch market in 2025?
The threat of new entrants is moderate. While the market offers growth potential, new entrants face significant barriers such as high capital investment in technology, stringent regulatory requirements, and the need to establish reliable supply chains for raw materials. Additionally, large, established players dominate the market, making entry challenging.
How strong is the bargaining power of suppliers in the pharmaceutical starch market in 2025?
The bargaining power of suppliers is moderate to high. Suppliers of raw materials, particularly agricultural products like corn and potatoes, have some influence due to fluctuations in crop yields and the limited number of suppliers in certain regions. However, the availability of alternative starch sources and production methods reduces supplier power to some extent.
What is the bargaining power of buyers in the pharmaceutical starch market in 2025?
The bargaining power of buyers is moderate. Pharmaceutical companies have a wide range of excipient options, including synthetic alternatives, which gives them some leverage over suppliers. However, the essential role of starch in drug formulations, along with its cost-effectiveness and compatibility, means that buyers are somewhat reliant on these suppliers.
How intense is the threat of substitute products in the pharmaceutical starch market in 2025?
The threat of substitutes is moderate. While starch is widely used as an excipient, there is increasing interest in synthetic and alternative excipients that offer enhanced functionalities, such as better stability or faster dissolution. However, the established use of starch in the industry, combined with its low cost and natural origin, makes it hard for substitutes to fully replace it.
How competitive is the pharmaceutical starch market in 2025?
The competition in the pharmaceutical starch market is moderate. There are several well-established players, but the market is also characterized by significant differentiation in terms of product innovation (such as modified starches for controlled release). While there is competition on price, the ability to offer high-quality, specialized products allows some differentiation, reducing direct price competition.
Market Upstream Analysis
What are the key raw materials in the upstream supply chain of the pharmaceutical starch market in 2025?
The key raw materials include starch-rich crops such as corn, potatoes, and wheat. These crops are cultivated and harvested to extract the starch, which is then processed and refined for use in pharmaceutical products. Alternative sources like tapioca or rice may also be explored in response to regional preferences or sustainability goals.
How will agricultural practices impact the pharmaceutical starch market in 2025?
Agricultural practices will play a critical role, as variations in crop yields due to climate change, water scarcity, or soil health could impact the availability and cost of raw materials. Additionally, sustainable farming practices and organic production methods will become increasingly important to meet consumer demand for eco-friendly and ethical sourcing.
What technological advancements are impacting the upstream supply chain of pharmaceutical starch in 2025?
Technological advancements in biotechnology, including genetic modifications and enzyme treatments, will allow for more efficient starch production and modification. Innovations in agricultural technology, such as precision farming and vertical farming, could also improve crop yields and quality, ensuring a more stable upstream supply chain for pharmaceutical starch.
What role do suppliers and intermediaries play in the upstream pharmaceutical starch market in 2025?
Suppliers and intermediaries are crucial for sourcing raw materials and ensuring consistent quality. These players bridge the gap between agricultural producers and starch manufacturers by processing and refining the raw starch before it reaches pharmaceutical companies. They may also handle logistics, inventory management, and compliance with regulatory standards.
How do regulatory factors impact the upstream supply chain in the pharmaceutical starch market?
Regulatory factors significantly impact the upstream supply chain by setting strict guidelines for agricultural practices, quality control, and safety standards for excipient use. Compliance with food safety regulations, environmental sustainability standards, and certification processes for organic or non-GMO products will influence the sourcing and production of pharmaceutical starch.
Market Midstream Analysis
What are the key processes involved in the midstream segment of the pharmaceutical starch market in 2025?
The key processes include the extraction and refinement of starch from raw agricultural materials, followed by the modification of starch to meet specific pharmaceutical requirements. This involves physical or chemical modifications such as pre-gelatinization or cross-linking to enhance the starch’s functionality, ensuring it meets standards for stability, bioavailability, and patient compliance.
How does the role of manufacturers affect the midstream pharmaceutical starch market in 2025?
Manufacturers in the midstream segment play a critical role in converting raw starch into specialized excipients used in drug formulations. They are responsible for ensuring the consistency and quality of modified starches, adhering to strict regulatory guidelines, and developing innovative starch formulations that align with the evolving needs of the pharmaceutical industry.
What technologies are influencing the midstream segment of the pharmaceutical starch market in 2025?
Technological innovations such as enzyme-assisted modification, advanced drying technologies, and nanotechnology are reshaping the midstream segment. These technologies improve the functionality of starch, enabling the production of high-performance excipients that enhance drug delivery, stability, and release profiles, thus addressing the growing demand for more effective pharmaceutical products.
How does quality control and regulatory compliance impact the midstream pharmaceutical starch market?
Quality control and regulatory compliance are paramount in the midstream segment, as starches used in pharmaceuticals must meet rigorous standards for safety, purity, and consistency. Manufacturers must adhere to Good Manufacturing Practices (GMP) and ensure their products comply with international pharmacopeia standards, ensuring the starch is safe for use in drug formulations.
What are the challenges faced by the midstream pharmaceutical starch market in 2025?
The midstream pharmaceutical starch market faces challenges such as fluctuations in raw material prices, the complexity of modifying starches to meet specific pharmaceutical needs, and the rising demand for sustainable and eco-friendly production methods. Additionally, maintaining consistent quality while scaling production to meet global demand remains a significant challenge for manufacturers.
Market Downstream Analysis
What are the key activities in the downstream segment of the pharmaceutical starch market in 2025?
The key activities in the downstream segment include the formulation of starch-based excipients into various pharmaceutical products such as tablets, capsules, and powders. It also involves collaboration with pharmaceutical companies to develop customized solutions, ensuring that starches are optimized for drug delivery systems, stability, and bioavailability.
How do pharmaceutical companies influence the downstream market for pharmaceutical starch in 2025?
Pharmaceutical companies are the primary consumers of pharmaceutical starch and play a crucial role in shaping demand. Their need for efficient, cost-effective, and functional excipients drives the development and adoption of specific starch formulations. Their focus on patient-centric solutions, such as controlled release or rapid dissolution drugs, will impact the types of starches in demand.
What trends are emerging in the downstream pharmaceutical starch market in 2025?
Emerging trends include the growing demand for plant-based, organic, and sustainable excipients, as well as innovations in starch-based formulations designed for targeted or controlled drug release. Additionally, the increasing adoption of personalized medicine is pushing for more customized starch solutions to meet specific therapeutic needs.
How do regulatory requirements impact the downstream pharmaceutical starch market?
Regulatory requirements in the downstream segment ensure that starch-based excipients meet the standards of safety, efficacy, and quality set by authorities like the FDA or EMA. Compliance with these regulations is critical for market acceptance, as pharmaceutical products containing starch must adhere to strict guidelines to guarantee consumer safety and meet industry standards.
What challenges does the downstream pharmaceutical starch market face in 2025?
The downstream pharmaceutical starch market faces challenges such as the increasing demand for specialized excipients, which may require more advanced production techniques. There is also pressure to maintain cost-effectiveness while ensuring that starch formulations meet evolving regulatory and quality standards. Additionally, competition from synthetic and alternative excipients is rising, creating pressure to innovate and differentiate starch-based products.
Chapter 1, to describe Pharmaceutical Starch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Starch, with price, sales, revenue and global market share of Pharmaceutical Starch from 2018 to 2023.
Chapter 3, the Pharmaceutical Starch competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Starch breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Starch market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Starch.
Chapter 14 and 15, to describe Pharmaceutical Starch sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Starch
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Starch Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Corn Starch
1.3.3 Potato Starch
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Starch Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tablets
1.4.3 Capsule
1.4.4 Granular Formulation
1.4.5 Others
1.5 Global Pharmaceutical Starch Market Size & Forecast
1.5.1 Global Pharmaceutical Starch Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Starch Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Starch Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Tereos
2.1.1 Tereos Details
2.1.2 Tereos Major Business
2.1.3 Tereos Pharmaceutical Starch Product and Services
2.1.4 Tereos Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Tereos Recent Developments/Updates
2.2 Cargill
2.2.1 Cargill Details
2.2.2 Cargill Major Business
2.2.3 Cargill Pharmaceutical Starch Product and Services
2.2.4 Cargill Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cargill Recent Developments/Updates
2.3 Roquette
2.3.1 Roquette Details
2.3.2 Roquette Major Business
2.3.3 Roquette Pharmaceutical Starch Product and Services
2.3.4 Roquette Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roquette Recent Developments/Updates
2.4 Visco Starch
2.4.1 Visco Starch Details
2.4.2 Visco Starch Major Business
2.4.3 Visco Starch Pharmaceutical Starch Product and Services
2.4.4 Visco Starch Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Visco Starch Recent Developments/Updates
2.5 Colorcon
2.5.1 Colorcon Details
2.5.2 Colorcon Major Business
2.5.3 Colorcon Pharmaceutical Starch Product and Services
2.5.4 Colorcon Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Colorcon Recent Developments/Updates
2.6 Agrana
2.6.1 Agrana Details
2.6.2 Agrana Major Business
2.6.3 Agrana Pharmaceutical Starch Product and Services
2.6.4 Agrana Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Agrana Recent Developments/Updates
2.7 Paramesu Biotech
2.7.1 Paramesu Biotech Details
2.7.2 Paramesu Biotech Major Business
2.7.3 Paramesu Biotech Pharmaceutical Starch Product and Services
2.7.4 Paramesu Biotech Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Paramesu Biotech Recent Developments/Updates
2.8 Shandong Liaocheng E Hua Pharmaceutical
2.8.1 Shandong Liaocheng E Hua Pharmaceutical Details
2.8.2 Shandong Liaocheng E Hua Pharmaceutical Major Business
2.8.3 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Product and Services
2.8.4 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shandong Liaocheng E Hua Pharmaceutical Recent Developments/Updates
2.9 SPAC Starch Products (India) Limited
2.9.1 SPAC Starch Products (India) Limited Details
2.9.2 SPAC Starch Products (India) Limited Major Business
2.9.3 SPAC Starch Products (India) Limited Pharmaceutical Starch Product and Services
2.9.4 SPAC Starch Products (India) Limited Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 SPAC Starch Products (India) Limited Recent Developments/Updates
2.10 Sanstar Biopolymers Ltd
2.10.1 Sanstar Biopolymers Ltd Details
2.10.2 Sanstar Biopolymers Ltd Major Business
2.10.3 Sanstar Biopolymers Ltd Pharmaceutical Starch Product and Services
2.10.4 Sanstar Biopolymers Ltd Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanstar Biopolymers Ltd Recent Developments/Updates
2.11 Ingredion
2.11.1 Ingredion Details
2.11.2 Ingredion Major Business
2.11.3 Ingredion Pharmaceutical Starch Product and Services
2.11.4 Ingredion Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Ingredion Recent Developments/Updates
2.12 Shandong Liujia
2.12.1 Shandong Liujia Details
2.12.2 Shandong Liujia Major Business
2.12.3 Shandong Liujia Pharmaceutical Starch Product and Services
2.12.4 Shandong Liujia Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Liujia Recent Developments/Updates
2.13 Universal Starch-Chem Allied Ltd
2.13.1 Universal Starch-Chem Allied Ltd Details
2.13.2 Universal Starch-Chem Allied Ltd Major Business
2.13.3 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Product and Services
2.13.4 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Universal Starch-Chem Allied Ltd Recent Developments/Updates
2.14 Hunan Er-Kang Pharmaceutical
2.14.1 Hunan Er-Kang Pharmaceutical Details
2.14.2 Hunan Er-Kang Pharmaceutical Major Business
2.14.3 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Product and Services
2.14.4 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hunan Er-Kang Pharmaceutical Recent Developments/Updates
2.15 Jiangxi Yipusheng Pharmaceutical
2.15.1 Jiangxi Yipusheng Pharmaceutical Details
2.15.2 Jiangxi Yipusheng Pharmaceutical Major Business
2.15.3 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Product and Services
2.15.4 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jiangxi Yipusheng Pharmaceutical Recent Developments/Updates
2.16 Shanxi Mr G Pharmaceutical
2.16.1 Shanxi Mr G Pharmaceutical Details
2.16.2 Shanxi Mr G Pharmaceutical Major Business
2.16.3 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Product and Services
2.16.4 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Shanxi Mr G Pharmaceutical Recent Developments/Updates
2.17 Shivangan Food & Pharma
2.17.1 Shivangan Food & Pharma Details
2.17.2 Shivangan Food & Pharma Major Business
2.17.3 Shivangan Food & Pharma Pharmaceutical Starch Product and Services
2.17.4 Shivangan Food & Pharma Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Shivangan Food & Pharma Recent Developments/Updates
2.18 Splenor Starch LLP
2.18.1 Splenor Starch LLP Details
2.18.2 Splenor Starch LLP Major Business
2.18.3 Splenor Starch LLP Pharmaceutical Starch Product and Services
2.18.4 Splenor Starch LLP Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Splenor Starch LLP Recent Developments/Updates
2.19 Weifang Shengtai Medicine
2.19.1 Weifang Shengtai Medicine Details
2.19.2 Weifang Shengtai Medicine Major Business
2.19.3 Weifang Shengtai Medicine Pharmaceutical Starch Product and Services
2.19.4 Weifang Shengtai Medicine Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Weifang Shengtai Medicine Recent Developments/Updates
2.20 Taishan Jinantang
2.20.1 Taishan Jinantang Details
2.20.2 Taishan Jinantang Major Business
2.20.3 Taishan Jinantang Pharmaceutical Starch Product and Services
2.20.4 Taishan Jinantang Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Taishan Jinantang Recent Developments/Updates
2.21 Anhui Sunhere Pharmaceutical Excipients
2.21.1 Anhui Sunhere Pharmaceutical Excipients Details
2.21.2 Anhui Sunhere Pharmaceutical Excipients Major Business
2.21.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Product and Services
2.21.4 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Starch by Manufacturer
3.1 Global Pharmaceutical Starch Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Starch Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Starch Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Starch by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Starch Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Starch Manufacturer Market Share in 2022
3.5 Pharmaceutical Starch Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Starch Market: Region Footprint
3.5.2 Pharmaceutical Starch Market: Company Product Type Footprint
3.5.3 Pharmaceutical Starch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Starch Market Size by Region
4.1.1 Global Pharmaceutical Starch Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Starch Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Starch Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Starch Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Starch Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Starch Consumption Value (2018-2029)
4.5 South America Pharmaceutical Starch Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Starch Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Starch Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Starch Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Starch Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Starch Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Starch Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Starch Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Starch Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Starch Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Starch Market Size by Country
7.3.1 North America Pharmaceutical Starch Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Starch Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Starch Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Starch Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Starch Market Size by Country
8.3.1 Europe Pharmaceutical Starch Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Starch Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Starch Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Starch Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Starch Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Starch Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Starch Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Starch Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Starch Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Starch Market Size by Country
10.3.1 South America Pharmaceutical Starch Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Starch Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Starch Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Starch Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Starch Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Starch Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Starch Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Starch Market Drivers
12.2 Pharmaceutical Starch Market Restraints
12.3 Pharmaceutical Starch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Starch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Starch
13.3 Pharmaceutical Starch Production Process
13.4 Pharmaceutical Starch Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Starch Typical Distributors
14.3 Pharmaceutical Starch Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Starch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Starch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Tereos Basic Information, Manufacturing Base and Competitors
Table 4. Tereos Major Business
Table 5. Tereos Pharmaceutical Starch Product and Services
Table 6. Tereos Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Tereos Recent Developments/Updates
Table 8. Cargill Basic Information, Manufacturing Base and Competitors
Table 9. Cargill Major Business
Table 10. Cargill Pharmaceutical Starch Product and Services
Table 11. Cargill Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Cargill Recent Developments/Updates
Table 13. Roquette Basic Information, Manufacturing Base and Competitors
Table 14. Roquette Major Business
Table 15. Roquette Pharmaceutical Starch Product and Services
Table 16. Roquette Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roquette Recent Developments/Updates
Table 18. Visco Starch Basic Information, Manufacturing Base and Competitors
Table 19. Visco Starch Major Business
Table 20. Visco Starch Pharmaceutical Starch Product and Services
Table 21. Visco Starch Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Visco Starch Recent Developments/Updates
Table 23. Colorcon Basic Information, Manufacturing Base and Competitors
Table 24. Colorcon Major Business
Table 25. Colorcon Pharmaceutical Starch Product and Services
Table 26. Colorcon Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Colorcon Recent Developments/Updates
Table 28. Agrana Basic Information, Manufacturing Base and Competitors
Table 29. Agrana Major Business
Table 30. Agrana Pharmaceutical Starch Product and Services
Table 31. Agrana Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Agrana Recent Developments/Updates
Table 33. Paramesu Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Paramesu Biotech Major Business
Table 35. Paramesu Biotech Pharmaceutical Starch Product and Services
Table 36. Paramesu Biotech Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Paramesu Biotech Recent Developments/Updates
Table 38. Shandong Liaocheng E Hua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Shandong Liaocheng E Hua Pharmaceutical Major Business
Table 40. Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Product and Services
Table 41. Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shandong Liaocheng E Hua Pharmaceutical Recent Developments/Updates
Table 43. SPAC Starch Products (India) Limited Basic Information, Manufacturing Base and Competitors
Table 44. SPAC Starch Products (India) Limited Major Business
Table 45. SPAC Starch Products (India) Limited Pharmaceutical Starch Product and Services
Table 46. SPAC Starch Products (India) Limited Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. SPAC Starch Products (India) Limited Recent Developments/Updates
Table 48. Sanstar Biopolymers Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Sanstar Biopolymers Ltd Major Business
Table 50. Sanstar Biopolymers Ltd Pharmaceutical Starch Product and Services
Table 51. Sanstar Biopolymers Ltd Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanstar Biopolymers Ltd Recent Developments/Updates
Table 53. Ingredion Basic Information, Manufacturing Base and Competitors
Table 54. Ingredion Major Business
Table 55. Ingredion Pharmaceutical Starch Product and Services
Table 56. Ingredion Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Ingredion Recent Developments/Updates
Table 58. Shandong Liujia Basic Information, Manufacturing Base and Competitors
Table 59. Shandong Liujia Major Business
Table 60. Shandong Liujia Pharmaceutical Starch Product and Services
Table 61. Shandong Liujia Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shandong Liujia Recent Developments/Updates
Table 63. Universal Starch-Chem Allied Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Universal Starch-Chem Allied Ltd Major Business
Table 65. Universal Starch-Chem Allied Ltd Pharmaceutical Starch Product and Services
Table 66. Universal Starch-Chem Allied Ltd Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Universal Starch-Chem Allied Ltd Recent Developments/Updates
Table 68. Hunan Er-Kang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Hunan Er-Kang Pharmaceutical Major Business
Table 70. Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Product and Services
Table 71. Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Hunan Er-Kang Pharmaceutical Recent Developments/Updates
Table 73. Jiangxi Yipusheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Jiangxi Yipusheng Pharmaceutical Major Business
Table 75. Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Product and Services
Table 76. Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangxi Yipusheng Pharmaceutical Recent Developments/Updates
Table 78. Shanxi Mr G Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Shanxi Mr G Pharmaceutical Major Business
Table 80. Shanxi Mr G Pharmaceutical Pharmaceutical Starch Product and Services
Table 81. Shanxi Mr G Pharmaceutical Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Shanxi Mr G Pharmaceutical Recent Developments/Updates
Table 83. Shivangan Food & Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Shivangan Food & Pharma Major Business
Table 85. Shivangan Food & Pharma Pharmaceutical Starch Product and Services
Table 86. Shivangan Food & Pharma Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Shivangan Food & Pharma Recent Developments/Updates
Table 88. Splenor Starch LLP Basic Information, Manufacturing Base and Competitors
Table 89. Splenor Starch LLP Major Business
Table 90. Splenor Starch LLP Pharmaceutical Starch Product and Services
Table 91. Splenor Starch LLP Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Splenor Starch LLP Recent Developments/Updates
Table 93. Weifang Shengtai Medicine Basic Information, Manufacturing Base and Competitors
Table 94. Weifang Shengtai Medicine Major Business
Table 95. Weifang Shengtai Medicine Pharmaceutical Starch Product and Services
Table 96. Weifang Shengtai Medicine Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Weifang Shengtai Medicine Recent Developments/Updates
Table 98. Taishan Jinantang Basic Information, Manufacturing Base and Competitors
Table 99. Taishan Jinantang Major Business
Table 100. Taishan Jinantang Pharmaceutical Starch Product and Services
Table 101. Taishan Jinantang Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Taishan Jinantang Recent Developments/Updates
Table 103. Anhui Sunhere Pharmaceutical Excipients Basic Information, Manufacturing Base and Competitors
Table 104. Anhui Sunhere Pharmaceutical Excipients Major Business
Table 105. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Product and Services
Table 106. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Anhui Sunhere Pharmaceutical Excipients Recent Developments/Updates
Table 108. Global Pharmaceutical Starch Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 109. Global Pharmaceutical Starch Revenue by Manufacturer (2018-2023) & (USD Million)
Table 110. Global Pharmaceutical Starch Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 111. Market Position of Manufacturers in Pharmaceutical Starch, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 112. Head Office and Pharmaceutical Starch Production Site of Key Manufacturer
Table 113. Pharmaceutical Starch Market: Company Product Type Footprint
Table 114. Pharmaceutical Starch Market: Company Product Application Footprint
Table 115. Pharmaceutical Starch New Market Entrants and Barriers to Market Entry
Table 116. Pharmaceutical Starch Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Pharmaceutical Starch Sales Quantity by Region (2018-2023) & (MT)
Table 118. Global Pharmaceutical Starch Sales Quantity by Region (2024-2029) & (MT)
Table 119. Global Pharmaceutical Starch Consumption Value by Region (2018-2023) & (USD Million)
Table 120. Global Pharmaceutical Starch Consumption Value by Region (2024-2029) & (USD Million)
Table 121. Global Pharmaceutical Starch Average Price by Region (2018-2023) & (USD/MT)
Table 122. Global Pharmaceutical Starch Average Price by Region (2024-2029) & (USD/MT)
Table 123. Global Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 124. Global Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 125. Global Pharmaceutical Starch Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Global Pharmaceutical Starch Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Global Pharmaceutical Starch Average Price by Type (2018-2023) & (USD/MT)
Table 128. Global Pharmaceutical Starch Average Price by Type (2024-2029) & (USD/MT)
Table 129. Global Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 130. Global Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 131. Global Pharmaceutical Starch Consumption Value by Application (2018-2023) & (USD Million)
Table 132. Global Pharmaceutical Starch Consumption Value by Application (2024-2029) & (USD Million)
Table 133. Global Pharmaceutical Starch Average Price by Application (2018-2023) & (USD/MT)
Table 134. Global Pharmaceutical Starch Average Price by Application (2024-2029) & (USD/MT)
Table 135. North America Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 136. North America Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 137. North America Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 138. North America Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 139. North America Pharmaceutical Starch Sales Quantity by Country (2018-2023) & (MT)
Table 140. North America Pharmaceutical Starch Sales Quantity by Country (2024-2029) & (MT)
Table 141. North America Pharmaceutical Starch Consumption Value by Country (2018-2023) & (USD Million)
Table 142. North America Pharmaceutical Starch Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Europe Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 144. Europe Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 145. Europe Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 146. Europe Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 147. Europe Pharmaceutical Starch Sales Quantity by Country (2018-2023) & (MT)
Table 148. Europe Pharmaceutical Starch Sales Quantity by Country (2024-2029) & (MT)
Table 149. Europe Pharmaceutical Starch Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Pharmaceutical Starch Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 152. Asia-Pacific Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 153. Asia-Pacific Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 154. Asia-Pacific Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 155. Asia-Pacific Pharmaceutical Starch Sales Quantity by Region (2018-2023) & (MT)
Table 156. Asia-Pacific Pharmaceutical Starch Sales Quantity by Region (2024-2029) & (MT)
Table 157. Asia-Pacific Pharmaceutical Starch Consumption Value by Region (2018-2023) & (USD Million)
Table 158. Asia-Pacific Pharmaceutical Starch Consumption Value by Region (2024-2029) & (USD Million)
Table 159. South America Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 160. South America Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 161. South America Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 162. South America Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 163. South America Pharmaceutical Starch Sales Quantity by Country (2018-2023) & (MT)
Table 164. South America Pharmaceutical Starch Sales Quantity by Country (2024-2029) & (MT)
Table 165. South America Pharmaceutical Starch Consumption Value by Country (2018-2023) & (USD Million)
Table 166. South America Pharmaceutical Starch Consumption Value by Country (2024-2029) & (USD Million)
Table 167. Middle East & Africa Pharmaceutical Starch Sales Quantity by Type (2018-2023) & (MT)
Table 168. Middle East & Africa Pharmaceutical Starch Sales Quantity by Type (2024-2029) & (MT)
Table 169. Middle East & Africa Pharmaceutical Starch Sales Quantity by Application (2018-2023) & (MT)
Table 170. Middle East & Africa Pharmaceutical Starch Sales Quantity by Application (2024-2029) & (MT)
Table 171. Middle East & Africa Pharmaceutical Starch Sales Quantity by Region (2018-2023) & (MT)
Table 172. Middle East & Africa Pharmaceutical Starch Sales Quantity by Region (2024-2029) & (MT)
Table 173. Middle East & Africa Pharmaceutical Starch Consumption Value by Region (2018-2023) & (USD Million)
Table 174. Middle East & Africa Pharmaceutical Starch Consumption Value by Region (2024-2029) & (USD Million)
Table 175. Pharmaceutical Starch Raw Material
Table 176. Key Manufacturers of Pharmaceutical Starch Raw Materials
Table 177. Pharmaceutical Starch Typical Distributors
Table 178. Pharmaceutical Starch Typical Customers
List of Figures
Figure 1. Pharmaceutical Starch Picture
Figure 2. Global Pharmaceutical Starch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Starch Consumption Value Market Share by Type in 2022
Figure 4. Corn Starch Examples
Figure 5. Potato Starch Examples
Figure 6. Others Examples
Figure 7. Global Pharmaceutical Starch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Pharmaceutical Starch Consumption Value Market Share by Application in 2022
Figure 9. Tablets Examples
Figure 10. Capsule Examples
Figure 11. Granular Formulation Examples
Figure 12. Others Examples
Figure 13. Global Pharmaceutical Starch Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Pharmaceutical Starch Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Pharmaceutical Starch Sales Quantity (2018-2029) & (MT)
Figure 16. Global Pharmaceutical Starch Average Price (2018-2029) & (USD/MT)
Figure 17. Global Pharmaceutical Starch Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Pharmaceutical Starch Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Pharmaceutical Starch by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Pharmaceutical Starch Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Pharmaceutical Starch Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Pharmaceutical Starch Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Pharmaceutical Starch Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Pharmaceutical Starch Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Pharmaceutical Starch Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Pharmaceutical Starch Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Pharmaceutical Starch Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Pharmaceutical Starch Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Pharmaceutical Starch Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Pharmaceutical Starch Average Price by Type (2018-2029) & (USD/MT)
Figure 32. Global Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Pharmaceutical Starch Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Pharmaceutical Starch Average Price by Application (2018-2029) & (USD/MT)
Figure 35. North America Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Pharmaceutical Starch Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Pharmaceutical Starch Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Pharmaceutical Starch Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Pharmaceutical Starch Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Pharmaceutical Starch Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Pharmaceutical Starch Consumption Value Market Share by Region (2018-2029)
Figure 55. China Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Pharmaceutical Starch Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Pharmaceutical Starch Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Pharmaceutical Starch Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Pharmaceutical Starch Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Pharmaceutical Starch Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Pharmaceutical Starch Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Pharmaceutical Starch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Pharmaceutical Starch Market Drivers
Figure 76. Pharmaceutical Starch Market Restraints
Figure 77. Pharmaceutical Starch Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Pharmaceutical Starch in 2022
Figure 80. Manufacturing Process Analysis of Pharmaceutical Starch
Figure 81. Pharmaceutical Starch Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
